K021890

Substantially Equivalent

G-2 VERSION 3, MODEL 10049

Applicant: Vitrolife Sweden AB
Product code: MQL
Advisory panel: Obstetrics/Gynecology
Date received: 2002-06-10
Decision date: 2002-09-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.